Skip to main content
logo
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
37.33
-0.10 (-0.27%)
Aug 8, 2025, 11:35 AM - Market open

Legend Biotech Revenue

Legend Biotech had revenue of $195.05M in the quarter ending March 31, 2025, with 107.52% growth. This brings the company's revenue in the last twelve months to $728.30M, up 112.46% year-over-year. In the year 2024, Legend Biotech had annual revenue of $627.24M with 119.97% growth.

Revenue (ttm)
$728.30M
Revenue Growth
+112.46%
P/S Ratio
9.42
Revenue / Employee
$279,150
Employees
2,609
Market Cap
6.88B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024627.24M342.10M119.97%
Dec 31, 2023285.14M168.14M143.70%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 202075.00M13.20M21.36%
Jan 1, 2020 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Novo Nordisk49.11B
Eli Lilly and Company49.00B
Revenue Rankings

LEGN News

More News